TY - JOUR
T1 - Health-related quality of life of Adolescent and Young Adult Cancer Survivors before and during the COVID-19 pandemic:
T2 - Longitudinal improvements on social functioning and fatigue
AU - Vlooswijk, C.
AU - Janssen, S.H.M.
AU - van de Poll-Franse, L.V.
AU - Bijlsma, R.
AU - Kaal, S.E. J.
AU - Kerst, M.
AU - Tromp, J.M.
AU - Bos, M.E.M.M.
AU - Lalisang, R.I.
AU - Nuver, J.
AU - Kouwenhoven, M.C.M.
AU - van der Graaf, W.T.A.
AU - Husson, O.
PY - 2023
Y1 - 2023
N2 - The health-related quality of life (HRQoL) among long-term Adolescent and Young Adult Cancer Survivors (AYACS) and an age- and sex-matched normative population was examined. Although the HRQoL of AYACS was worse compared to the normative population before and during the COVID-19 pandemic, the scores of AYACS improved over time in contrast to the normative population. Presumably, AYACS are used to adjusting their lives to stressful life events. Furthermore, the lockdown may have been beneficial for AYACS who face difficulties fully participating in society due to the impact of cancer. AYACS who encounter HRQoL issues could benefit from support interventions to empower them and build resilience.
AB - The health-related quality of life (HRQoL) among long-term Adolescent and Young Adult Cancer Survivors (AYACS) and an age- and sex-matched normative population was examined. Although the HRQoL of AYACS was worse compared to the normative population before and during the COVID-19 pandemic, the scores of AYACS improved over time in contrast to the normative population. Presumably, AYACS are used to adjusting their lives to stressful life events. Furthermore, the lockdown may have been beneficial for AYACS who face difficulties fully participating in society due to the impact of cancer. AYACS who encounter HRQoL issues could benefit from support interventions to empower them and build resilience.
U2 - 10.1186/s41687-023-00629-0
DO - 10.1186/s41687-023-00629-0
M3 - Article
SN - 2509-8020
VL - 7
JO - Journal of Patient-Reported Outcomes
JF - Journal of Patient-Reported Outcomes
IS - 93
ER -